BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Chen X, Tang M. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. Oncol Rep. 2014;32:2824-2830. [PMID: 25220761 DOI: 10.3892/or.2014.3478] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Mortoglou M, Tabin ZK, Arisan ED, Kocher HM, Uysal-Onganer P. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Transl Oncol 2021;14:101090. [PMID: 33831655 DOI: 10.1016/j.tranon.2021.101090] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tian YS, Zhong D, Liu QQ, Zhao XL, Sun HX, Jin J, Wang HN, Li GZ. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways. J Neurosurg 2018;130:977-88. [PMID: 29521586 DOI: 10.3171/2017.5.JNS163165] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
3 Wang W, Wang J, Yang C, Wang J. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis. IUBMB Life 2021;73:866-82. [PMID: 33759343 DOI: 10.1002/iub.2468] [Reference Citation Analysis]
4 Qin RF, Zhang J, Huo HR, Yuan ZJ, Xue JD. MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation. World J Gastroenterol 2019; 25(28): 3775-3786 [PMID: 31391772 DOI: 10.3748/wjg.v25.i28.3775] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
5 Nan Y, Wu C, Zhang YJ. Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism. Front Immunol 2017;8:1758. [PMID: 29312301 DOI: 10.3389/fimmu.2017.01758] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
6 Yonemori K, Kurahara H, Maemura K, Natsugoe S. MicroRNA in pancreatic cancer. J Hum Genet 2017;62:33-40. [DOI: 10.1038/jhg.2016.59] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 13.6] [Reference Citation Analysis]
7 Eichmüller SB, Osen W, Mandelboim O, Seliger B. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape. J Natl Cancer Inst 2017;109. [PMID: 28383653 DOI: 10.1093/jnci/djx034] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 18.3] [Reference Citation Analysis]
8 Fu D, Dong J, Li P, Tang C, Cheng W, Xu Z, Zhou W, Ge J, Xia C, Zhang Z. MiRNA-21 has effects to protect kidney injury induced by sepsis. Biomed Pharmacother 2017;94:1138-44. [PMID: 28821165 DOI: 10.1016/j.biopha.2017.07.098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
9 Liu H, Pan Y, Han X, Liu J, Li R. MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway. Onco Targets Ther 2017;10:2701-9. [PMID: 28579808 DOI: 10.2147/OTT.S114318] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
10 Sharma GG, Okada Y, Von Hoff D, Goel A. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma. Semin Cancer Biol 2020:S1044-579X(20)30204-2. [PMID: 33049362 DOI: 10.1016/j.semcancer.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Mills EA, Goldman D. The Regulation of Notch Signaling in Retinal Development and Regeneration. Curr Pathobiol Rep 2017;5:323-31. [PMID: 29354328 DOI: 10.1007/s40139-017-0153-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
12 Sun L, Chua CY, Tian W, Zhang Z, Chiao PJ, Zhang W. MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma. J Genet Genomics. 2015;42:563-577. [PMID: 26554910 DOI: 10.1016/j.jgg.2015.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
13 Song Y, Tang MY, Chen W, Wang Z, Wang SL. High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Dis Markers 2020;2020:7656031. [PMID: 33029256 DOI: 10.1155/2020/7656031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tu CC, Zhong Y, Nguyen L, Tsai A, Sridevi P, Tarn WY, Wang JY. The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage. Sci Signal 2015;8:ra64. [PMID: 26126715 DOI: 10.1126/scisignal.aaa4468] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
15 Akbari A, Majd HM, Rahnama R, Heshmati J, Morvaridzadeh M, Agah S, Amini SM, Masoodi M. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers. Biomed Pharmacother 2020;131:110729. [PMID: 33152911 DOI: 10.1016/j.biopha.2020.110729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wang D, Li Y, Zhang C, Li X, Yu J. MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5. J Cell Biochem 2018;119:1755-66. [DOI: 10.1002/jcb.26336] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
17 Gong R, Jiang Y. Non-coding RNAs in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020;10:309. [PMID: 32257946 DOI: 10.3389/fonc.2020.00309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
18 Taucher V, Mangge H, Haybaeck J. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol 2016;39:295-318. [DOI: 10.1007/s13402-016-0275-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
19 Zhang J, Xu K, Shi L, Zhang L, Zhao Z, Xu H, Liang F, Li H, Zhao Y, Xu X, Tian Y. Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5. Oncol Res 2017;25:1317-27. [PMID: 28256193 DOI: 10.3727/096504017X14874323871217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
20 Sarwar A, Wang B, Su Q, Zhang Y. MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer. Biochem Pharmacol 2021;189:114357. [PMID: 33279497 DOI: 10.1016/j.bcp.2020.114357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yu JE, Ju JA, Musacchio N, Mathias TJ, Vitolo MI. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer. Biomolecules 2020;10:E1646. [PMID: 33302540 DOI: 10.3390/biom10121646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tandon M, Coudriet GM, Criscimanna A, Socorro M, Eliliwi M, Singhi AD, Cruz-Monserrate Z, Bailey P, Lotze MT, Zeh H, Hu J, Goffin V, Gittes GK, Biankin AV, Esni F. Prolactin Promotes Fibrosis and Pancreatic Cancer Progression. Cancer Res 2019;79:5316-27. [PMID: 31395607 DOI: 10.1158/0008-5472.CAN-18-3064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
23 赵银瑞, 张连峰, 赵萍, 周琳. miR216a及其靶基因JAK2CSK在胰腺癌中的表达及临床意义. 世界华人消化杂志 2015; 23(34): 5458-5464 [DOI: 10.11569/wcjd.v23.i34.5458] [Reference Citation Analysis]
24 Nagaraju GP, Madanraj AS, Aliya S, Rajitha B, Alese OB, Kariali E, Alam A, El-Rayes BF. MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers. Tumour Biol. 2016;37:97-104. [PMID: 26537581 DOI: 10.1007/s13277-015-4346-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
25 Liao X, Huang R, Wang X, Huang K, Yang C, Zhou X, Han C, Su H, Ye X, Liu K, Zhu G, Peng T. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy. J Cancer 2021;12:2122-39. [PMID: 33754011 DOI: 10.7150/jca.46084] [Reference Citation Analysis]
26 Bynigeri RR, Jakkampudi A, Jangala R, Subramanyam C, Sasikala M, Rao GV, Reddy DN, Talukdar R. Pancreatic stellate cell: Pandora's box for pancreatic disease biology. World J Gastroenterol 2017; 23(3): 382-405 [PMID: 28210075 DOI: 10.3748/wjg.v23.i3.382] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 72] [Article Influence: 20.5] [Reference Citation Analysis]
27 Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, Singh M, Bagga P, Das BC, Bedognetti D, Reddy R, Frenneaux MP, El-Rifai W, Siddiqi MA, Haris M, Macha MA. miRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol 2021:S1084-9521(21)00086-0. [PMID: 33926791 DOI: 10.1016/j.semcdb.2021.04.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Omar HA, El‐serafi AT, Hersi F, Arafa EA, Zaher DM, Madkour M, Arab HH, Tolba MF. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment. FEBS J 2019;286:3540-57. [DOI: 10.1111/febs.15000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
29 Zhang L, Li J, Wang Q, Meng G, Lv X, Zhou H, Li W, Zhang J. The relationship between microRNAs and the STAT3-related signaling pathway in cancer. Tumour Biol 2017;39:1010428317719869. [PMID: 28859543 DOI: 10.1177/1010428317719869] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
30 Lu S, Ahmed T, Du P, Wang Y. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. Int J Mol Sci 2017;18:E1201. [PMID: 28587243 DOI: 10.3390/ijms18061201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Vorvis C, Koutsioumpa M, Iliopoulos D. Developments in miRNA gene signaling pathways in pancreatic cancer. Future Oncol. 2016;12:1135-1150. [PMID: 26984178 DOI: 10.2217/fon-2015-0050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
32 Zhen Q, Gao LN, Wang RF, Chu WW, Zhang YX, Zhao XJ, Lv BL, Liu JB. LncRNA DANCR Promotes Lung Cancer by Sequestering miR-216a. Cancer Control 2018;25:1073274818769849. [PMID: 29651883 DOI: 10.1177/1073274818769849] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
33 Rachagani S, Macha MA, Menning MS, Dey P, Pai P, Smith LM, Mo YY, Batra SK. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget 2015;6:40295-309. [PMID: 26516699 DOI: 10.18632/oncotarget.5641] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
34 Li J, Sun P, Yue Z, Zhang D, You K, Wang J. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway. DNA and Cell Biology 2017;36:619-26. [DOI: 10.1089/dna.2017.3656] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
35 Sun T, An Q, Yan R, Li K, Zhu K, Dang C, Yuan D. MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101. Oncol Rep 2020;44:1971-84. [PMID: 32901882 DOI: 10.3892/or.2020.7751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Wu BL, Wang D, Bai WJ, Zhang F, Zhao X, Yi Y, Zhang T, Shen WJ, Li EM, Xu LY, Xu JZ. An integrative framework to identify cell death-related microRNAs in esophageal squamous cell carcinoma. Oncotarget 2016;7:56758-66. [PMID: 27462775 DOI: 10.18632/oncotarget.10779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Rawat M, Kadian K, Gupta Y, Kumar A, Chain PSG, Kovbasnjuk O, Kumar S, Parasher G. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes (Basel) 2019;10:E752. [PMID: 31557962 DOI: 10.3390/genes10100752] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
38 Yang H, Lu Z, Huo C, Chen Y, Cao H, Xie P, Zhou H, Liu D, Liu J, Yu L. Liang-Ge-San, a Classic Traditional Chinese Medicine Formula, Attenuates Lipopolysaccharide-Induced Acute Lung Injury Through Up-Regulating miR-21. Front Pharmacol 2019;10:1332. [PMID: 31803051 DOI: 10.3389/fphar.2019.01332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 Garg M, Shanmugam MK, Bhardwaj V, Goel A, Gupta R, Sharma A, Baligar P, Kumar AP, Goh BC, Wang L, Sethi G. The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy. Med Res Rev 2020. [PMID: 33289118 DOI: 10.1002/med.21761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
40 Wei HT, Guo EN, Liao XW, Chen LS, Wang JL, Ni M, Liang C. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma. Oncol Rep 2018;40:1947-58. [PMID: 30066920 DOI: 10.3892/or.2018.6607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
41 Wu X, Chen W, Cai H, Hu J, Wu B, Jiang Y, Chen X, Sun D, An Y. MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS. Arch Med Sci 2018;14:1321-32. [PMID: 30393486 DOI: 10.5114/aoms.2018.72564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
42 Jin P, Liu Y, Wang R. STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance. Biosci Rep 2018;38:BSR20180547. [PMID: 30061175 DOI: 10.1042/BSR20180547] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
43 Yang Z, Song C, Jiang R, Huang Y, Lan X, Lei C, Chen H. Micro-Ribonucleic Acid-216a Regulates Bovine Primary Muscle Cells Proliferation and Differentiation via Targeting SMAD Nuclear Interacting Protein-1 and Smad7. Front Genet 2019;10:1112. [PMID: 31798627 DOI: 10.3389/fgene.2019.01112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]